Your browser doesn't support javascript.
loading
GSK114: A selective inhibitor for elucidating the biological role of TNNI3K.
Lawhorn, Brian G; Philp, Joanne; Graves, Alan P; Shewchuk, Lisa; Holt, Dennis A; Gatto, Gregory J; Kallander, Lara S.
Afiliação
  • Lawhorn BG; Heart Failure DPU, GlaxoSmithKline, 709 Swedeland Road, King of Prussia, PA 19406, USA. Electronic address: brian.2.lawhorn@gsk.com.
  • Philp J; Heart Failure DPU, GlaxoSmithKline, 709 Swedeland Road, King of Prussia, PA 19406, USA.
  • Graves AP; Platform Sciences and Technology, GlaxoSmithKline, 709 Swedeland Road, King of Prussia, PA 19406, USA.
  • Shewchuk L; Platform Sciences and Technology, GlaxoSmithKline, 709 Swedeland Road, King of Prussia, PA 19406, USA.
  • Holt DA; Heart Failure DPU, GlaxoSmithKline, 709 Swedeland Road, King of Prussia, PA 19406, USA.
  • Gatto GJ; Heart Failure DPU, GlaxoSmithKline, 709 Swedeland Road, King of Prussia, PA 19406, USA.
  • Kallander LS; Heart Failure DPU, GlaxoSmithKline, 709 Swedeland Road, King of Prussia, PA 19406, USA.
Bioorg Med Chem Lett ; 26(14): 3355-3358, 2016 Jul 15.
Article em En | MEDLINE | ID: mdl-27246618

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quinazolinas / Sulfonamidas / MAP Quinase Quinase Quinases / Inibidores de Proteínas Quinases Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quinazolinas / Sulfonamidas / MAP Quinase Quinase Quinases / Inibidores de Proteínas Quinases Idioma: En Ano de publicação: 2016 Tipo de documento: Article